Genfit S.A., together with its subsidiaries, engages in the research and development of medicines and diagnostic solutions in France and internationally. The company offers elafibranor for the treatment of primary biliary cholangitis; and NIS, a non-invasive diagnostic technology for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops elafibranor, which is in Phase 3 clinical trial for the treatment of primary sclerosing cholangitis; GNS561, which is in Phase 1b c...
Industry: Biotechnology
Sector: Healthcare
Phone: 33 3 20 16 40 00
Address:
Parc Eurasanté, 885, Avenue Eugène Avinée, Loos, France
